A Non-Interventional, Multicenter, Prospective, Observational Study to Understand Usage and Effect of AZilsartan as MonothErapy or Add On TreatmeNt in Indian PaTients with Hypertension - ZENITH

Torrent Pharmaceuticals Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1.Patient willing to provide informed consent
•2.Female or male patient aged 18 years or above
•3.A treatment naive patient or a patient who are on treatment with other antihypertensive with grade 1 and 2 hypertension (SBP between 150 to 180)
•4.Physician decides to prescribe azilsartan as a monotherapy or add-on
•5.Patients must provide written consent to use personal and/or health data prior to the entry into the study

•1.Confirmed secondary hypertension
•2.Patient taking a medicine acts upon RAAS e.g. ACEi or ARBs other than Azilsartan
•3.Contraindications for azilsartan of respective approved local prescribing information.
•4.Any reasons of medical and non-medical character, which in the opinion of the physician can prevent subject participation in the study
•5.Pregnant and lactating woman and women of child bearing potential not ready to use an effective barrier contraceptive method during the study

发起方

Torrent Pharmaceuticals Ltd